Literature DB >> 18075284

Evaluation of proopiomelanocortin mRNA in the peripheral blood from patients with Cushing's syndrome of different origin.

S Bondioni1, G Mantovani, N Polentarutti, B Ambrosi, P Loli, E Peverelli, A G Lania, P Beck-Peccoz, A Spada.   

Abstract

ACTH-dependent Cushing's syndrome is due to ACTH overproduction originating from a pituitary corticotroph adenoma (Cushing's disease) or from ectopic tumors (ectopic ACTH syndrome). Due to difficulties in the differential diagnosis between these two forms of hypercortisolism it would be important to have molecular tools able to discriminate the two conditions. It is known that proopiomelanocortin (POMC) gene transcription can originate messengers of different length. ACTHomas show the normal 1072 nucleotides (nt) transcript, whereas ectopic tumors seem to be associated with a longer mRNA form (1450 nt). In order to analyse the presence of different POMC transcripts, we extracted total RNA from peripheral lymphocytes of 10 patients with Cushing's disease, 10 with ectopic Cushing syndrome, and 20 controls as well as from pituitary tissues (2 ACTH-omas and a normal pituitary polyA+ sample). Northern blot analysis correctly revealed a 1072 nt mRNA molecule in pituitary ACTH-oma and in the normal pituitary polyA+ RNA samples, whereas neither this molecule nor other alternative transcripts were detected in blood samples from patients and controls. These data were confirmed by the more sensitive RT-PCR technique. This study further underlines the need for alternative approaches in the diagnosis of ACTH-dependent Cushing's syndrome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18075284     DOI: 10.1007/BF03349223

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  27 in total

1.  Structural organization of human genomic DNA encoding the pro-opiomelanocortin peptide.

Authors:  A C Chang; M Cochet; S N Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

2.  High precursor level in maternal blood results from the alternate mode of proopiomelanocortin processing in human placenta.

Authors:  M L Raffin-Sanson; J F Massias; A Ankotche; J Coste; Y de Keyzer; C Oliver; C Dumont; D Cabrol; F Ferré; X Bertagna
Journal:  Clin Endocrinol (Oxf)       Date:  1999-01       Impact factor: 3.478

3.  Pro-opiomelanocortin gene expression in human phaeochromocytomas.

Authors:  Y de Keyzer; M F Rousseau-Merck; J P Luton; F Girard; A Kahn; X Bertagna
Journal:  J Mol Endocrinol       Date:  1989-05       Impact factor: 5.098

4.  Regulation of the pro-opiomelanocortin mRNA levels in rat pituitary by dopaminergic compounds.

Authors:  C L Chen; F T Dionne; J L Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

Review 5.  Polymerase chain reaction in the detection of micrometastases and circulating tumor cells.

Authors:  R A Ghossein; J Rosai
Journal:  Cancer       Date:  1996-07-01       Impact factor: 6.860

6.  Highly sensitive serum thyroglobulin and circulating thyroglobulin mRNA evaluations in the management of patients with differentiated thyroid cancer in apparent remission.

Authors:  Laura Fugazzola; Alessandra Mihalich; Luca Persani; Nadia Cerutti; Michela Reina; Marco Bonomi; Emanuela Ponti; Deborah Mannavola; Enza Giammona; Guia Vannucchi; Anna Maria di Blasio; Paolo Beck-Peccoz
Journal:  J Clin Endocrinol Metab       Date:  2002-07       Impact factor: 5.958

7.  Characterization of proopiomelanocortin transcripts in human nonpituitary tissues.

Authors:  T Lacaze-Masmonteil; Y de Keyzer; J P Luton; A Kahn; X Bertagna
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

8.  Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood.

Authors:  M D Ringel; P W Ladenson; M A Levine
Journal:  J Clin Endocrinol Metab       Date:  1998-12       Impact factor: 5.958

9.  Aberrant production and regulation of proopiomelanocortin-derived peptides in ectopic Cushing's syndrome.

Authors:  K A Roth; D C Newell; R I Dorin; J H Eberwine; A R Hoffman
Journal:  Horm Metab Res       Date:  1988-04       Impact factor: 2.936

10.  Proopiomelanocortin gene product regulation in keratinocytes.

Authors:  M Wintzen; M Yaar; J P Burbach; B A Gilchrest
Journal:  J Invest Dermatol       Date:  1996-04       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.